More articles (current) News & expert insights (recommended)
Skip to main content
Read Article
Read Article
Read Article 
Read Article
Read Article
Read Article
Insights
There is always something exciting happening at Lockton. Here are just a few from our newsroom.
1 / 6
— Articles
Cyber Risk Discussion Guide for Boardrooms
Cybersecurity is no longer just a technology issue, it is a boardroom responsibility with direct implications for business resilience, regulatory compliance, financial performance, and stakeholder trust. The Cyber Risk Discussion Guide for Boardrooms …
— Articles
HEALTHCARE
Advancing transparency, trust, and organizational resilience in healthcare
Patients visit healthcare organizations expecting to receive treatments or therapies that improve their health or offer relief from an illness. While the vast majority of patients receive safe, effective care and experience positive outcomes, unexpec …
— Articles
Third-party litigation funding reforms gain momentum, but liability market pressures persi …
Third-party litigation funding has become an increasingly important driver of social inflation, which has resulted in rapidly growing casualty claim severity. State lawmakers are finally responding, with reforms ranging from North Carolina’s first-in …
— Articles
New social media litigation risks bring governance and insurance into focus
In March 2026, a California jury ordered Meta and YouTube to pay $6 million to a plaintiff who alleged that childhood use of social media platforms contributed to addiction, anxiety, depression, and other mental health harms. For companies of the def …
— Articles
Cell & gene therapy: Preparing for the next phase of employer health plan risk
Cell and gene therapies are often viewed as an emerging wave of multimillion-dollar costs for employer health plans. While these therapies can exceed $2 million-$4 million per treatment, current employer exposure remains limited because utilization h …
— Alert
Reminder: PCORI filing due July 31
The Patient-Centered Outreach Research Institute (PCORI) fee is a temporary charge on both fully insured and self-funded healthcare plans, applicable for policy years from 2012 to 2029. This fee funds the Patient-Centered Outcomes Research Institute, …
